Retrospective review of patients with lentigo maligna treated with topical imiquimod 5% (Aldara®) at a single tertiary UK centre: need for more practical standardised treatment guidelines in the UK
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llad332 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Usamah M Afzal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Hauptthemen laut MEDLINE: Hutchinson's Melanotic Freckle, Antineoplastic Agents, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Lentigo maligna (LM) is an in situ melanoma that arises on chronically sun-damaged skin, predominantly on the head and neck. While surgery is the gold standard treatment for LM, imiquimod 5% (Aldara®), an immune response modifier, is a well-reported off-licence treatment in both primary and adjuvant settings. Although NICE suggests considering treatment with imiquimod, there are, as yet, no formal guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
ORCID-Profile: Usamah M Afzal
Zitieren
APA
Afzal, U. M., Ghadiri, S. J., Sambi, P., Muinonen-Martin, A., & Mitra, A. (2024). Retrospective review of patients with lentigo maligna treated with topical imiquimod 5% (Aldara®) at a single tertiary UK centre: need for more practical standardised treatment guidelines in the UK. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad332
Vancouver
Afzal UM, Ghadiri SJ, Sambi P, Muinonen-Martin A, Mitra A. Retrospective review of patients with lentigo maligna treated with topical imiquimod 5% (Aldara®) at a single tertiary UK centre: need for more practical standardised treatment guidelines in the UK. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llad332
BibTeX
@article{Afzal2024,
author = {Afzal, Usamah M and Ghadiri, Sina J and Sambi, Pavan and Muinonen-Martin, Andrew and Mitra, Angana},
title = {Retrospective review of patients with lentigo maligna treated with topical imiquimod 5% (Aldara®) at a single tertiary UK centre: need for more practical standardised treatment guidelines in the UK},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llad332}
}
EUVIMED